KIDS logo

OrthoPediatrics Corp. (KIDS)

$16.30

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on KIDS

Market cap

$408760479

EPS

-1.96

P/E ratio

--

Price to sales

1.87

Dividend yield

--

Beta

1.120297

Price on KIDS

Previous close

$16.96

Today's open

$16.89

Day's range

$16.17 - $16.89

52 week range

$15.28 - $26.40

Profile about KIDS

CEO

David R. Bailey

Employees

562

Headquarters

Warsaw, IN

Exchange

NASDAQ Global Market

Shares outstanding

25077330

Issue type

Common Stock

KIDS industries and sectors

Healthcare

Medical Equipment & Supplies

News on KIDS

OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

WARSAW, Ind., Feb. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes.

news source

GlobeNewsWire • Feb 12, 2026

news preview

OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity

OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and older OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and older

news source

GlobeNewsWire • Feb 3, 2026

news preview

OrthoPediatrics (KIDS) Moves 9.8% Higher: Will This Strength Last?

OrthoPediatrics (KIDS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

news source

Zacks Investment Research • Jan 13, 2026

news preview

OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance

Achieves all-time high full year 2025 Revenue of $236.1 million representing growth of 15% over prior year Initiates guidance for record Adjusted EBITDA in 2026

news source

GlobeNewsWire • Jan 12, 2026

news preview

Wall Street Analysts Think OrthoPediatrics (KIDS) Could Surge 26.45%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

news source

Zacks Investment Research • Nov 26, 2025

news preview

OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Product Launches

WARSAW, Ind., Nov. 13, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) portfolio with two new products launches, the PediHip™ Rigid Brace and PediHip™ Modular Abduction Systems. The company now has 31 systems within its OPSB division.

news source

GlobeNewsWire • Nov 13, 2025

news preview

Wall Street Analysts Believe OrthoPediatrics (KIDS) Could Rally 41.92%: Here's is How to Trade

The consensus price target hints at a 41.9% upside potential for OrthoPediatrics (KIDS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

news source

Zacks Investment Research • Nov 10, 2025

news preview

OrthoPediatrics to Participate in Upcoming Conferences

WARSAW, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in three upcoming investor conferences.

news source

GlobeNewsWire • Nov 4, 2025

news preview

OrthoPediatrics Corp. (KIDS) Q3 2025 Earnings Call Transcript

OrthoPediatrics Corp. (NASDAQ:KIDS ) Q3 2025 Earnings Call October 28, 2025 4:30 PM EDT Company Participants David Bailey - President, CEO & Director Fred Hite - CFO, Principal Financial & Accounting Officer, COO and Director Conference Call Participants Philip Taylor - Gilmartin Group LLC David Turkaly - Citizens JMP Securities, LLC, Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Ravi Misra - Truist Securities, Inc., Research Division Presentation Operator Good afternoon, and welcome to the OrthoPediatrics Corporation Third Quarter 2025 Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.

news source

Seeking Alpha • Oct 29, 2025

news preview

OrthoPediatrics Corp. Reports Third Quarter 2025 Financial Results

WARSAW, Ind., Oct. 28, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the third quarter ended September 30, 2025.

news source

GlobeNewsWire • Oct 28, 2025

news preview

¹ Disclosures

Get started with M1

Invest in OrthoPediatrics Corp.

Open an M1 investment account to buy and sell OrthoPediatrics Corp. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in KIDS on M1